The largest database of trusted experimental protocols

15 protocols using hscrp

1

Plasma Cytokine and NT ProBNP Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
As outlined above, all participants underwent analysis of plasma markers of Tumor Necrosis Factor alpha (TNF-α), Interleukin-6 (IL-6), high sensitivity C-Reactive Protein (CRP), IL-8, and IL-10 at five separate time periods. N-terminal prohormone of brain natriuretic peptide (NT ProBNP) was also assessed. All blood samples were drawn into blood collection tubes from the antecubital vein (with the participant in a seated position) and then immediately immersed in a refrigerated centrifuge and centrifuged within 15 min of collection. Plasma levels of each cytokine (TNF-α, IL-6, IL-8, IL-10, and CRP) and NT ProBNP were measured using a commercially available high-sensitivity ELISA (enzyme-linked immunosorbent assay) kits [Biosource (IL-8, IL-10, TNF-α), Biocheck (hsCRP), R & D Systems (IL-6)] according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Cardiovascular Disease Biomarker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was collected for laboratory analysis of inflammatory and lipid markers. Tumor necrosis factor (TNF-α), high sensitivity c-reactive protein (hs-CRP), oxidized low-density lipoprotein (ox-LDL), Low-density lipoproteins (LDL), apolipoprotein-B (apo-B), and triglycerides were selected based on their biological roles in CVD.
TNF-α (R&D Systems, Minneapolis, MN), hs-CRP (BN-100 nephelmometer, Dade Behring, Deerfield, IN), and ox-LDL (Mercodia AB, Uppsala, Sweden) were assessed in blood plasma by ELISA following their respective manufacturers’ directions. Triglycerides, total cholesterol, and high-density lipoproteins (HDL) were measured on the Vitro 950 Chemistry Station (Ortho-Clinical Diagnostics, Raritan, NJ) as per the manufacturer’s directions. LDL was calculated based on the subtraction of HDL from the total cholesterol measurements. Apo-B was assessed on a protein analyzer as per the manufacturer (BN ProSpec System, Dade Behring).
+ Open protocol
+ Expand
3

Biomarker Quantification in Gut Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zonulin (Promocell Germany), BDG (Mybiosource Inc. CA), I-FABP, sCD14, sCD163, sTNFRI, hsCRP, IL-6 (R &D Systems, Minneapolis, Minnesota, USA) and oxidized LDL (ALPCO, Salem, New Hampshire, USA and Mercodia, Uppsala, Sweden) were measured by ELISA . The intra-assay variability ranged between 4-8% and inter-assay variability was less than 10% for all markers. All assays were done at Dr Funderburg’s laboratory at Ohio State University, Columbus, OH (https://u.osu.edu/caffre/people/nicholas-t-funderburg-ph-d/). Laboratory personnel were blinded to group assignments.
+ Open protocol
+ Expand
4

Inflammatory Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The blood collected was stored at −80°C and batched until processing without a prior thaw. Then using enzyme-linked immunosorbent assay (ELISA), we measured the following inflammatory markers: soluble tumor necrosis factor receptors I (sTNFR-I), High sensitivity C reactive protein (hs-CRP), interleukin 6 (IL-6) (R&D systems, Minneapolis, Minnesota, USA), and D-dimer (Diagnostica Stago, USA). We also measured by ELISA oxidized low-density lipoprotein (Ox-LDL) (Uppsala, Mercodia, Sweden) and two gut markers; lipopolysaccharide-binding protein (LBP) (Hycult Biotech Inc. Pennsylvania, USA), a marker of microbial translocation, and zonulin (Promocell, Germany), a marker of gut permeability. All measurements were done at Dr. Funderburg’s laboratory at Ohio State University, Columbus, Ohio.
+ Open protocol
+ Expand
5

Plasma Glucose and Inflammation Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose was analyzed by a glucose oxidase assay (YSI Instruments 2700, Yellow Springs, OH). Remaining samples were centrifuged at 4°C for 10 min at 3000 RPM and stored at -80°C until analysis. Plasma insulin (Millipore, Billerica, MA) as well as hs-CRP, VCAM, and ICAM (R&D Systems, Minneapolis, MN) were batched analyzed in duplicate to minimize variance within conditions using ELISA.
+ Open protocol
+ Expand
6

Biomarker Quantification in Metabolic Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of glucose (BioAssay Systems, Hayward, CA) and insulin (Mercodia, Uppsala, Sweden), as well as leptin, adiponectin, high sensitivity C-reactive protein (hsCRP), and interleukin-6 (IL-6; R&D Systems, Minneapolis, MN) were measured by enzyme-linked immunosorbent assay (ELISA). Serum levels of total, HDL, and LDL cholesterol and triglycerides were determined in the clinical chemistry laboratory at MSKCC. Coefficients of variation for intra-assay variation for quality control samples were less than 7%.
+ Open protocol
+ Expand
7

Biomarkers of Immune Activation and CVD Risk in HIV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measurements were performed by the Dahms Clinical Research Unit Core Laboratory [Dr McComsey, laboratory Director]. In this analysis, we selected biomarkers based on prior data in HIV suggesting their association with CVD, metabolic complications, or overall mortality. Intestinal fatty acid binding protein (I-FABP) is considered a marker of enterocyte damage and has been associated with increased mortality[20 (link), 21 (link)]. Soluble CD14 (sCD14) is a soluble marker of monocyte activation and microbial translocation and is associated with mortality and progression of atherosclerosis[26 ]. Oxidized lipids (oxidized LDL) is the form of LDL that has undergone oxidative changes and has been shown to contribute to endothelial cell activation[22 (link)]. The remaining biomarkers [soluble CD163 (sCD163), interleukin-6 (IL-6), and soluble tumor necrosis alpha receptor II (sTNFRII)] correlate with cardiometabolic complications, or drive other hallmarks of immune dysregulation in HIV.
I-FABP, sCD14, sCD163, sTNFRII, hsCRP, IL-6 (R &D Systems, Minneapolis, Minnesota, USA) and oxidized LDL (Mercodia, Winston Salem, North Carolina, USA) were measured by ELISA. The intra-assay variability ranged between 4–8% and inter-assay variability was less than 11% for all markers. Laboratory personnel were blinded to group assignments.
+ Open protocol
+ Expand
8

Biomarkers of Inflammation, Coagulation, and Gut Barrier

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was stored at −80°C and batched until processing without prior thaw. Enzyme-linked immunosorbent assay assays were performed to measure markers of systemic inflammation (soluble tumor necrosis factor receptors I and II, high sensitivity C-reactive protein [hsCRP], interleukin 6 [IL-6] [R &D Systems, Minneapolis, Minnesota]), coagulation:d-dimer (Diagnostica Stago, Parsippany, New Jersey), and oxidized low-density lipoprotein assays (Uppsala, Mercodia, Sweden), as well as markers of monocyte activation soluble CD14 and CD163 (R&D Systems, Minneapolis, Minnesota).[20 (link)–23 (link)] The soluble intercellular adhesion molecule 1 was measured by Enzyme-linked immunosorbent assays (R&D Systems, Minneapolis, Minnesota).[24 (link)] A marker of gut permeability: zonulin-1 (Promocell Germany), a marker of microbial translocation (Levels of lipopolysaccharide-binding protein [LBP, Hycult Biotech Inc. Pennsylvenia]), and a marker of fungal translocation β-D-glucan (Mybiosource Inc. California) were measured to assess gut-barrier integrity.[25 (link)–27 (link)]
+ Open protocol
+ Expand
9

Cytokine and Chemokine Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokine and chemokine concentrations were determined in supernatants using DuoSet ELISA for TNFα, IL-6, IL-8, IL-10, IL-1β, IL-17 and IL-22 (R&D), and interferon gamma (IFN-γ) (Sanquin). Plasma hsCRP concentrations were obtained (R&D). Circulating IL-1β, IL-1Ra, IL-6 and IL-18 concentrations were sensitively measured using SimplePlex cartridge on the Ella platform (Protein Simple, San Jose, USA).
+ Open protocol
+ Expand
10

Quantification of Metabolic Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA and FFA assay kits were performed using commercially available mouse ELISA kits. ELISA kits for insulin (Novusbio), hs-CRP (R&D systems), and VLDL (MyBioSource, San Diego, CA, USA) were used according to the manufacturer’s instructions. The assay sensitivity was < 0.19 ng/mL for insulin, < 0.015 ng/mL for hs-CRP, and < 0.195 ng/mL for VLDL. The intra- and inter-assay coefficients of variance were < 5.9% and < 6.4% for insulin, < 7.7% and < 10.8% for hs-CRP, and < 8% and < 10% for VLDL, respectively. Quantification of FFA was performed using commercially assay kit (Abcam), according to the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!